Can electronic cigarettes assist patients with smoking cessation?: Yes;Les cigarettes électroniques peuvent-elles aider les patients à cesser de fumer?: Oui

Canadian Family Physician

Volumn 61, Issue 6, 2015, Pages

  Kaplan, Alan ^a,b,c  

^a Brampton Civic Hospital ^*  (Canada)

^b University of Queensland   (Canada)

^c Medecins de Famille en Sante Respiratoire Comite de Programme Sur la Medecine Respiratoire   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANABASINE; FOOD PRESERVATIVE; NITROSAMINE; PROPYLENE GLYCOL; TOBACCO SMOKE; TOXIC SUBSTANCE; NICOTINE GUM;

ASTHMA; CANADA; ELECTRONIC CIGARETTE; HABIT; HARM REDUCTION; HUMAN; INHALER; SHORT SURVEY; SMOKING; SMOKING CESSATION; STRESS; TOBACCO DEPENDENCE; PROCEDURES; PSYCHOLOGY;

ELECTRONIC CIGARETTES; HUMANS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 84931022155     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004;(4):CD000031.
2. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE et coll. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296(1):56-63.
3. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;(3):CD000146.
4. US Department of Health and Human Services. The health consequences of smoking - 50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
5. Henningfield JE, Zaatari GS. Electronic nicotine delivery systems: emerging science foundation for policy. Tob Control 2010;19(2):89-90.
6. Westenberger BJ. Evaluation of e-cigarettes. St Louis, MO: Department of Health and Human Services, Food and Drug Administration; 2009. Accessible à: www.fda.gov/downloads/drugs/Scienceresearch/UCM173250.pdf. Réf. du 10 avr. 2015.
7. BMA response to MHRA's announcement on e-cigarettes [press release]. Londres, RU: British Medical Association; 2013.
8. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and everuse of electronic cigarettes among US adults, 2010-2011. Nicotine Tob Res 2013;15(9):1623-7. Publ. en ligne du 28 févr. 2013.
9. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav 2014;39(2):491-4. Publ. en ligne du 30 oct. 2013.
10. US Department of Health and Human Services. Why do you smoke? Bethesda, MD: National Cancer Institute; 1992. Accessible à: http://rtips.cancer.gov/rtips/viewProduct.do?viewMode=product&productId=189980. Réf. du 10 avr. 2015.
11. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C et coll. Efficiency and Safety of an Electronic Cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8(6):e66317. Erratum dans: PLoS One 2014;9(1).
12. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A et coll. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 2014;9(5):537-46. Publ. en ligne du 20 ju0ill. 2013.